OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2
Chen Chen, Veda Sheersh Boorla, Deepro Banerjee, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 42
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
Wenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110210-110210
Open Access | Times Cited: 128

The Spike of Concern—The Novel Variants of SARS-CoV-2
Anna Winger, Thomas Caspari
Viruses (2021) Vol. 13, Iss. 6, pp. 1002-1002
Open Access | Times Cited: 111

A unified evolution-driven deep learning framework for virus variation driver prediction
Zhiwei Nie, Xudong Liu, Jie Chen, et al.
Nature Machine Intelligence (2025)
Closed Access | Times Cited: 3

SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
Ahmed M. Almehdi, Ghalia Khoder, Aminah Alchakee, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 855-876
Open Access | Times Cited: 91

Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
Joseph T. Ortega, Beata Jastrzȩbska, Héctor R. Rangel
Pathogens (2021) Vol. 11, Iss. 1, pp. 45-45
Open Access | Times Cited: 60

Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 59

Biophysics of SARS-CoV-2 spike protein’s receptor-binding domain interaction with ACE2 and neutralizing antibodies: from computation to functional insights
Fernando Luís Barroso da Silva, Karen Paco, Aatto Laaksonen, et al.
Biophysical Reviews (2025)
Closed Access | Times Cited: 1

SARS-CoV-2 Omicron (B.1.1.529) Infection of Wild White-Tailed Deer in New York City
Kurt J. Vandegrift, Michele Yon, Meera Surendran Nair, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2770-2770
Open Access | Times Cited: 31

Free Energy Perturbation Calculations of Mutation Effects on SARS-CoV-2 RBD::ACE2 Binding Affinity
Alina P. Sergeeva, Phinikoula S. Katsamba, Junzhuo Liao, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 15, pp. 168187-168187
Open Access | Times Cited: 17

Biophysical principles predict fitness of SARS-CoV-2 variants
D. I. C. Wang, Marian Huot, Vaibhav Mohanty, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 23
Open Access | Times Cited: 8

The Development of SARS-CoV-2 Variants: The Gene Makes the Disease
Raquel Pérez-Gómez
Journal of Developmental Biology (2021) Vol. 9, Iss. 4, pp. 58-58
Open Access | Times Cited: 37

Molecular insights into the differential dynamics of SARS-CoV-2 variants of concern
Nabanita Mandal, Aditya K. Padhi, Soumya Lipsa Rath
Journal of Molecular Graphics and Modelling (2022) Vol. 114, pp. 108194-108194
Open Access | Times Cited: 25

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
Lianlian Bian, Jianyang Liu, Fan Gao, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 24

Structural evolution of Delta lineage of SARS-CoV-2
Mohammad Mahmoudi Gomari, Parastoo Tarighi, Edris Choupani, et al.
International Journal of Biological Macromolecules (2022) Vol. 226, pp. 1116-1140
Open Access | Times Cited: 21

When the Dust Has Settled: Calculation of Binding Affinities from First Principles for SARS-CoV-2 Variants with Quantitative Accuracy
Emma Goulard Coderc de Lacam, Marharyta Blazhynska, Haochuan Chen, et al.
Journal of Chemical Theory and Computation (2022) Vol. 18, Iss. 10, pp. 5890-5900
Closed Access | Times Cited: 20

Binding affinity between coronavirus spike protein and human ACE2 receptor
Marcus Ho-Hin Shum, Yang Lee, Leighton Tam, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 759-770
Open Access | Times Cited: 4

Phage-Displayed Mimotopes of SARS-CoV-2 Spike Protein Targeted to Authentic and Alternative Cellular Receptors
Valery A. Petrenko, James W. Gillespie, Laura M. De Plano, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 384-384
Open Access | Times Cited: 19

Beta, Delta, and Omicron, Deadliest Among SARS-CoV-2 Variants: A Computational Repurposing Approach
Mohammad Mamun Alam, Sumaiya Binte Hannan, Tanvir Ahmed Saikat, et al.
Evolutionary Bioinformatics (2023) Vol. 19
Open Access | Times Cited: 10

Unveiling the ghost: machine learning’s impact on the landscape of virology
Sebastian Bowyer, David J. Allen, Nicholas Furnham
Journal of General Virology (2025) Vol. 106, Iss. 1
Closed Access

Secondary metabolites of Alternaria alternate appraisal of their SARS-CoV-2 inhibitory and anti-inflammatory potentials
Fatma A. Moharram, Reham R. Ibrahim, Shahenda Mahgoub, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313616-e0313616
Open Access

Serological Assays Reveal No Evidence of Natural SARS-CoV-2 Infection in US Cattle
Santhamani Ramasamy, Meysoon Quraishi, Swastidipa Mukherjee, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 600-600
Open Access

Viral escape-inspired framework for structure-guided dual bait protein biosensor design
Yee Chuen Teoh, Mohammed Sakib Noor, Sina Aghakhani, et al.
PLoS Computational Biology (2025) Vol. 21, Iss. 4, pp. e1012964-e1012964
Open Access

Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo
Alişan Kayabölen, Uğur Akcan, Doğancan Özturan, et al.
Advanced Science (2022) Vol. 9, Iss. 27
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top